Synthesis and evaluation of 2'-hydroxyethyl trans-apovincaminate derivatives as antioxidant and cognitive enhancer agents

Journal of Medicinal Chemistry
András NemesCsaba Szántay

Abstract

A series of trans-2'-hydroxyethyl and 2'-acyloxyethyl apovincaminates 4b- f and 7b- f has been synthesized and evaluated for their antioxidant and antiamnesic effects. The new esters were prepared from 4a and 7a ethyl esters or from the corresponding carboxylic acid sodium salt. For starting materials 11a, b, a new stereoselective trans-reduction was elaborated. From the combined results of the data obtained from in vitro and in vivo tests and examination of the metabolism, (3 R,16 S)-2'-hydroxyethyl apovincaminate ( 7b, RGH-10885) was identified as the most promising compound, owing to its potent neuroprotective and antiamnesic activities. The in vivo effectiveness of selected compounds on the cognitive functions was studied in a one-trial passive avoidance task and a water-labyrinth test.

References

Apr 1, 1985·European Journal of Drug Metabolism and Pharmacokinetics·L Vereczkey
Aug 1, 1981·Journal of Neurochemistry·T J Player, A A Horton
Jan 1, 1994·Physiological Reviews·B P Yu
Nov 26, 1999·The New England Journal of Medicine·R Mayeux, M Sano
Jan 7, 2000·Free Radical Research·M S SantosC R Oliveira
Dec 13, 2000·Brain Research Bulletin·P BönöczkA Vas
Sep 15, 2004·Progress in Neuro-psychopharmacology & Biological Psychiatry·Ke CuiM R Ven Murthy
Dec 25, 2004·Psychopharmacology·Judit LaszyIstván Gyertyán
Sep 15, 2005·Medicinal Research Reviews·Adám Vas, Balázs Gulyás

❮ Previous
Next ❯

Citations

May 11, 2011·Chemical Communications : Chem Comm·Kazuhiro HiguchiTomomi Kawasaki
Dec 1, 2010·Cognitive Science·Linda B SmithHanako Yoshida

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.